Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01881386 : Lactate Imaging as a Tumour Biomarker
PhaseN/A
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

Cohort 1:lymphoma patients

- minimum lesion size of 2cm

- not pretreated but scheduled to be treated with CHOP (Cyclophosphamide,
Hydroxydaunomycin,Oncovin and Prednisolone)

Cohort 2:Colorectal patients

- metastatic disease of at least 2cm

- not pretreated

Cohort 3:Phase 1 Drug Development

- minimum lesion size at least 2cm

Cohort 4: Brain

- primary brain tumours receiving radiotherapy and temozolomide

- cerebral lymphoma receiving standard chemotherapy

Exclusion Criteria:

- MRI incompatible metal implants

- Claustrophobia

- Inability to tolerate a 40 minute MRI scan
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01881386      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740